Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis (original) (raw)

• Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602–611.
  Article CAS Google Scholar
• Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 2007; 61: 427–434.
  Article CAS Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130–133.
  Article CAS Google Scholar
• Chen-Plotkin AS, Lee VM, Trojanowski JQ . TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol 2010; 6: 211–220.
  Article CAS Google Scholar
• Tatom JB, Wang DB, Dayton RD, Skalli O, Hutton ML, Dickson DW et al. Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig’s disease in rats via TDP-43 overexpression. Mol. Ther. 2009; 17: 607–613.
  Article CAS Google Scholar
• Wang DB, Dayton RD, Henning PP, Cain CD, Zhao LR, Schrott LM et al. Expansive gene transfer to the rat CNS and amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther 2010; 18: 2064–2074.
  Article CAS Google Scholar
• Dayton RD, Gitcho MA, Orchard EA, Wilson JD, Wang DB, Cain CD et al. Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol Ther 2013; 21: 1324–1334.
  Article CAS Google Scholar
• Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S . Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 2010; 30: 639–649.
  Article CAS Google Scholar
• Wang DB, Gitcho MA, Kraemer BC, Klein RL . Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis. Eur J Neurosci 2011; 34: 1179–1188.
  Article Google Scholar
• Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet 2012; 44: 1302–1309.
  Article CAS Google Scholar
• Hebron M, Chen W, Miessau MJ, Lonskava I, Moussa CE . Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis. J Neurochem. 2013; 129: 305–361.
  Google Scholar
• Kim HJ, Raphael AR, Ladow ES, McGurk L, Weber RA, Trojanowski JQ et al. Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet. 2013; 46: 152–160.
  Article Google Scholar
• Vaccaro A, Patten SA, Ciura S, Maios C, Therrien M, Drapeau P et al. Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio. PLoS One 2012; 7: e42117.
  Article CAS Google Scholar
• Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci USA 2012; 109: 15024–15029.
  Article CAS Google Scholar
• Karam R, Wengrod J, Gardner LB, Wilkinson MF . Regulation of nonsense-mediated mRNA decay: implications for physiology and disease. Biochim Biophys Acta 2013; 1829: 624–633.
  Article CAS Google Scholar
• Popp MW, Maquat LE . Organizing principles of mammalian nonsense-mediated mRNA decay. Annu Rev Genet 2013; 47: 139–165.
  Article CAS Google Scholar
• Nguyen LS, Wilkinson MF, Gecz J . Nonsense-mediated mRNA decay: Inter-individual variability and human disease. Neurosci. Biobehav. Rev. 2013; S0149-7634: 270–274.
  Google Scholar
• Barmada S, Ju S, Arjun A, Batarse A, Qu H, Huang EE, et al. RNA helicases ameliorate ALS- and FTD related neurotoxicity. Ann Neurol 2013; 74: S93.
  Google Scholar
• Ju S, Tardiff DF, Han H, Divya K, Zhong Q, Maquat LE et al. A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol 2011; 9: e1001052.
  Article CAS Google Scholar
• Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK . Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 2009; 27: 59–65.
  Article CAS Google Scholar
• Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011; 14: 459–468.
  Article CAS Google Scholar
• Klein RL, Hamby ME, Hirko AC, Gong Y, Wang S, Hughes JA et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 2002; 176: 66–74.
  Article CAS Google Scholar
• Loeb JE, Cordier WS, Harris ME, Weitzman MD, Hope TJ . Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther 1995; 10: 2295–2305.
  Article Google Scholar
• Gitcho MA, Bigio EH, Mishra M, Johnson N, Weintraub S, Mesulam M et al. TARDBP 3′-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol 2009; 118: 633–645.
  Article CAS Google Scholar
• Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 2010; 107: 3858–3863.
  Article CAS Google Scholar
• Wang HY, Wang IF, Bose J, Shen CK . Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 2004; 83: 130–139.
  Article CAS Google Scholar
• Avendaño-Vázquez SE, Dhir A, Bembich S, Buratti E, Proudfood N, Baralle FE . Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 2012; 26: 1679–1684.
  Article Google Scholar
• Ayala YM, De Conti L, Avendaño-Vázquez SE, Dhir A, Romano M, D’Ambrogio A et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 2011; 30: 277–288.
  Article CAS Google Scholar
• Wengrod J, Martin L, Wang D, Frischmeyer-Guerrerio P, Dietz HC, Gardner LB . Inhibition of nonsense-mediated RNA decay activates autophagy. Mol Cell Biol 2013; 33: 2128–2135.
  Article CAS Google Scholar
• Kervestin S, Jacobson A . NMD: a multifaceted response to premature translational termination. Nat Rev Mol Cell Biol 2012; 13: 700–712.
  Article CAS Google Scholar
• Isken O, Kim YK, Hosoda N, Mayeur GL, Hershey JW, Maquat LE . Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell 2008; 133: 314–327.
  Article CAS Google Scholar
• Kurosaki T, Li W, Hoque M, Popp M.W.-L., Ermolenko DN, Tian B, Maquat LE . A post-translational regulatory switch on UPF1 controls targeted mRNA degradation. Genes Dev 2014; 28: 1900–1916.
  Article CAS Google Scholar
• Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, Wilson JM . Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78: 6381–6388.
  Article CAS Google Scholar
• Dayton RD, Wang DB, Klein RL . The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin Biol Ther 2012; 12: 757–766.
  Article CAS Google Scholar
• Duque S, Joussemet B, Riviere C, Marais T, Dubreil L, Douar AM et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther 2009; 17: 1187–1196.
  Article CAS Google Scholar
• Fu H, Dirosario J, Killedar S, Zaraspe K, McCarty DM . Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood–brain barrier gene delivery. Mol Ther 2011; 19: 1025–1033.
  Article CAS Google Scholar
• Weinberg MS, Samulski RJ, McCown TJ . Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 2013; 69: 82–88.
  Article CAS Google Scholar
• Gong C, Kim YK, Woeller CF, Tang Y, Maquat LE . SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs. Genes Dev 2009; 23: 54–66.
  Article CAS Google Scholar
• Kurosaki T, Maquat LE . Rules that govern UPF1 binding to mRNA 3’UTRs. Proc Natl Acad Sci USA 2013; 110: 3357–3362.
  Article CAS Google Scholar